Viewing Study NCT02236195

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:36 PM
Ignite Modification Date: 2026-02-21 @ 9:25 PM
Study NCT ID: NCT02236195
Status: COMPLETED
Last Update Posted: 2017-09-01
First Post: 2014-09-04
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Mocetinostat in Patients With Urothelial Carcinoma Having Inactivating Alterations of Specific Genes
Sponsor: Mirati Therapeutics Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Urothelial Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Urothelial View
None Bladder View
None HDAC View
None MGCD0103 View
None Mocetinostat View
None CREBBP View
None EP300 View
None Mirati View
None MethylGene View